When an Exome Test Is Part of the Therapy and Not a Diagnostic:

John West on Personalis and Personalized Cancer Vaccines

John West, CEO, Personalis
John West discusses how Personalis is participating in the dramatic shift in drug development toward immuno-oncology drugs.

2019-01-09T11:26:52+00:00